|
US2008222744A1
|
|
In vivo transfection in avians
|
|
US2008171696A1
|
|
Pharmacodynamically enhanced therapeutic proteins
|
|
WO2008115440A1
|
|
Pharmacodynamically enhanced therapeutic proteins
|
|
US2008124787A1
|
|
Microinjection devices and methods of use
|
|
US2008071067A1
|
|
Methods of purifying proteins from egg white
|
|
US2008124792A1
|
|
Hybrid promoters
|
|
US2008222743A1
|
|
RNA interference and disease resistance in avians
|
|
AU2007201063A1
|
|
Ovomucoid promoter and methods of use
|
|
BRPI0709552A2
|
|
composition and method for increasing white blood cell count in a patient
|
|
CN101405299A
|
|
Glycosylated G-CSF
|
|
CN101291684A
|
|
Glycolated and glycosylated poultry derived therapeutic proteins
|
|
US2006286638A1
|
|
Cell lines
|
|
US2006174364A1
|
|
Artificial chromosomes and transchromosomic avians
|
|
WO2006093847A1
|
|
Artificial chromosomes and transchromosomic avians
|
|
US2006159658A1
|
|
Methods of treating disease with glycosylated interferon
|
|
US2006123504A1
|
|
Methods of producing polyclonal antibodies
|
|
WO2006042214A1
|
|
Modified integrase and methods of use
|
|
EP1812568A2
|
|
Rna interference in avians
|
|
US2005273873A1
|
|
Genomic modification
|
|
US2005246783A1
|
|
Microinjection devices and methods of use
|
